Bioxytran (BIXT) Inventory Average (2011 - 2018)
Bioxytran (BIXT) posted Inventory Average of $6657.5 for Q2 2018, up 11.1% sequentially from $5992.5 in Q1 2018, and up 15.93% YoY from $5742.5 in Q2 2017.
Bioxytran (BIXT) Inventory Average (2011 - 2018) Analysis & Trends
Bioxytran has reported Inventory Average for 7 years, with the latest figure at $6657.5 in Q2 2018.
- Quarterly Inventory Average rose 15.93% year-over-year to $6657.5 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $6657.5 (up 15.93% YoY) and the FY2017 annual result came in at $5768.0, changed N/A from the prior year.
- Inventory Average improved to $6657.5 in Q2 2018 per BIXT's latest filing, from $5992.5 in the prior quarter.
- Over five years, Inventory Average peaked at $14114.0 in Q1 2014 and troughed at $4957.0 in Q4 2016.
- A 4-year average of $8121.4 and a median of $6022.2 in 2017 frame the typical range for Inventory Average.
- The widest YoY moves for Inventory Average: up 25.3% in 2014, down 17.13% in 2014.
- Over 4 years, Inventory Average stood at $12614.0 in 2014, then plunged by 60.7% to $4957.0 in 2016, then rose by 8.69% to $5388.0 in 2017, then rose by 23.56% to $6657.5 in 2018.
- According to Business Quant data, Inventory Average over the past three periods registered $6657.5, $5992.5, and $5388.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 6,657.50 |
| Mar 31, 2018 | 5,992.50 |
| Dec 31, 2017 | 5,388.00 |
| Sep 30, 2017 | 5,582.50 |
| Jun 30, 2017 | 5,742.50 |
| Mar 31, 2017 | 6,052.00 |
| Dec 31, 2016 | 4,957.00 |
| Sep 30, 2014 | 12,614.00 |
| Jun 30, 2014 | 14,114.00 |
| Mar 31, 2014 | 14,114.00 |
| Dec 31, 2013 | 14,365.50 |
| Sep 30, 2013 | 15,221.00 |
| Jun 30, 2013 | 13,253.50 |
| Mar 31, 2013 | 11,264.00 |
| Dec 31, 2012 | 12,529.50 |
| Sep 30, 2012 | 10,393.00 |
| Jun 30, 2012 | 8,340.00 |
| Mar 31, 2012 | 17,267.00 |
| Dec 31, 2011 | 23,248.50 |
| Sep 30, 2011 | 14,878.50 |